S&P 500

5.954,50

1,59%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
OncoVista Innovative Therapies Inc (CE) (OVIT)
OncoVista Innovative Therapies Inc (CE) (OVIT) Notícias

OVIT

OncoVista Innovative The... (CE) (OVIT)

OncoVista Innovative Therapies Inc (CE)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:OVIT

1

Data	Hora	Fonte	Título	Código	Companhia
09/05/2016	15:23	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
27/04/2016	11:02	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
08/04/2016	07:03	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
12/11/2015	09:10	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
15/04/2015	12:20	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
23/03/2015	13:06	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
07/11/2012	15:33	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
15/08/2012	14:44	Marketwired	Midday Movers on the OTCBB: HPCS, AMPW, OVIT, CSWG	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
10/07/2012	09:00	Marketwired	FDA Approves OncoVista's Phase I Clinical Trial of New Drug Candidate (OVI-117) for Solid Tumors	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
30/03/2012	15:23	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
14/03/2012	13:39	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
28/11/2011	17:33	Marketwired	OncoVista Innovative Therapies Engages Oncology Therapeutic Development to Initiate a Phase Ib Study of Cordycepin in Patient...	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
11/05/2011	08:01	Marketwired	Report: OncoVista Positioning Itself for the Next Level	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
28/04/2011	15:05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
10/03/2011	12:35	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
06/01/2011	13:19	Edgar (US Regulatory)	Confidential Treatment Order (CT ORDER)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
23/12/2010	09:40	Edgar (US Regulatory)	Amended Quarterly Report (10-Q/A)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
15/05/2009	18:16	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
09/04/2009	11:18	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
21/08/2008	15:57	Marketwired	(OVIT.OB) OncoVista Issued $16 Price Target From Status Equity Research	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
21/08/2008	08:30	Marketwired	Status Equity Research Initiates Coverage of OncoVista Innovative Therapies, Inc. (OVIT.OB) -- Long Term Target Price $16.00	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
14/08/2008	17:46	Edgar (US Regulatory)	Oncovista Innovative Therapies, Inc - Quarterly Report (10-Q)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
17/06/2008	11:06	Edgar (US Regulatory)	Oncovista Innovative Therapies, Inc - Confidential Treatment Order (CT ORDER)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
02/05/2008	18:43	Edgar (US Regulatory)	Oncovista Innovative Therapies, Inc - Amended Current report filing (8-K/A)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
29/04/2008	17:26	Edgar (US Regulatory)	Oncovista Innovative Therapies, Inc - Current report filing (8-K)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
14/04/2008	18:21	Edgar (US Regulatory)	Oncovista Innovative Therapies, Inc - Annual Report (Small Business Issuers) (10KSB)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
31/03/2008	16:52	Edgar (US Regulatory)	Oncovista Innovative Therapies, Inc - Notification that Annual Report will be submitted late (NT 10-K)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
06/02/2008	14:51	Edgar (US Regulatory)	Oncovista Innovative Therapies, Inc - Statement of Ownership (SC 13G)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
18/01/2008	15:40	Edgar (US Regulatory)	Oncovista Innovative Therapies, Inc - Prospectus filed pursuant to Rule 424(b)(3) (424B3)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
14/01/2008	09:00	Edgar (US Regulatory)	Oncovista Innovative Therapies, Inc - Notice of Effectiveness (EFFECT)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)